Subjects taking antipsychotics tricyclic antidepressants anxiolytics sedative hypnotics including non-benzodiazepines central opioid agonists/antagonists monoamine oxidase inhibitors MAOIs within at least 5 half lives or for at least 2 weeks whichever is longer prior to randomization 